A pilot study of the acceptability, feasibility and safety of yoga for chronic pain in sickle cell disease

Objectives: To determine the acceptability, feasibility and safety of yoga for chronic pain in sickle cell disease. Design and Setting: In Part A of this two-part study, adolescents with SCD and chronic pain (Group 1) and their parent (Group 2) completed a survey designed to capture pain characteris...

Full description

Saved in:
Bibliographic Details
Main Authors: Nitya Bakshi (Author), Anthony Cooley (Author), Diana Ross (Author), Lauren Hawkins (Author), Marlysa Sullivan (Author), Rachel Astles (Author), Cynthia Sinha (Author), Deeksha Katoch (Author), Manasa Peddineni (Author), Beatrice E. Gee (Author), Peter A. Lane (Author), Lakshmanan Krishnamurti (Author)
Format: Book
Published: Elsevier, 2021-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_697a48e8a008453ab7a1b8d6eb38015e
042 |a dc 
100 1 0 |a Nitya Bakshi  |e author 
700 1 0 |a Anthony Cooley  |e author 
700 1 0 |a Diana Ross  |e author 
700 1 0 |a Lauren Hawkins  |e author 
700 1 0 |a Marlysa Sullivan  |e author 
700 1 0 |a Rachel Astles  |e author 
700 1 0 |a Cynthia Sinha  |e author 
700 1 0 |a Deeksha Katoch  |e author 
700 1 0 |a Manasa Peddineni  |e author 
700 1 0 |a Beatrice E. Gee  |e author 
700 1 0 |a Peter A. Lane  |e author 
700 1 0 |a Lakshmanan Krishnamurti  |e author 
245 0 0 |a A pilot study of the acceptability, feasibility and safety of yoga for chronic pain in sickle cell disease 
260 |b Elsevier,   |c 2021-06-01T00:00:00Z. 
500 |a 0965-2299 
500 |a 10.1016/j.ctim.2021.102722 
520 |a Objectives: To determine the acceptability, feasibility and safety of yoga for chronic pain in sickle cell disease. Design and Setting: In Part A of this two-part study, adolescents with SCD and chronic pain (Group 1) and their parent (Group 2) completed a survey designed to capture pain characteristics, attitudes and practices related to yoga, and potential acceptability of a yoga program. In Part B, the study assessed the feasibility and safety of an instructor-led group yoga program. The study was registered on clinicaltrials.gov (NCT03694548). Intervention: Eight instructor-led group yoga sessions. Main Outcome Measures: Feasibility and safety outcomes were chosen a priori, as follows: 1) Proportion of adolescent patients with SCD and chronic pain approached that consent to participate in Part A, 2) Proportion of adolescent participants enrolled in Part A that consent to participate in Part B, 3) Proportion of participants enrolled in Part B that attend at least 6 of 8 yoga sessions, 4) Proportion of participants enrolled in Part B with an ED visit or a hospitalization for pain within 24 h of completion of each yoga session, 5) Proportion of participants in Part B who complete all study assessments before, and at the end of the yoga program, 6) Adherence to submission of pain diary. Results: The median age of 15 patient participants in Part A was 16 (IQR 14−17), and 14 parents was 43.5 (IQR 42−51). Most participants were female. Most participant responses indicated a positive opinion of yoga.Nine adolescents (60 %) from Part A participated in Part B of the study. The median age of 9 participants in Part B was 17 (IQR 15−18), and 5 of the 9 participants were female (53.3 %). Only one participant was able to attend 3 of the 8 yoga sessions offered, and did not experience any ED visits or hospitalizations following the yoga sessions. None of the other feasibility endpoints were met in this study. Conclusions: Patients with SCD and chronic pain overall have a positive opinion of yoga, but there are challenges with recruitment and retention of participants in a clinical trial of yoga, and barriers to feasibility of an in-person group yoga intervention. 
546 |a EN 
690 |a Sickle cell 
690 |a Chronic pain 
690 |a Yoga 
690 |a Feasibility 
690 |a Clinical trial 
690 |a Other systems of medicine 
690 |a RZ201-999 
655 7 |a article  |2 local 
786 0 |n Complementary Therapies in Medicine, Vol 59, Iss , Pp 102722- (2021) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S0965229921000637 
787 0 |n https://doaj.org/toc/0965-2299 
856 4 1 |u https://doaj.org/article/697a48e8a008453ab7a1b8d6eb38015e  |z Connect to this object online.